[5-min read] Q&A with Cory Firth, Advisor & Impact Coach
[5-min read] New study explores the effects of psychedelics in adolescents.
[5-min read] Q&A with Wendy Tucker, Artist & Publisher
[5-min read] FDA advisory committee weighs in on MDMA.
[5-min read] Q&A with Mary Olivar, Director of Development
[5-min read] NY bill would legalize psilocybin use with a permit.
[5-min read] Q&A with Christopher Solomon, Somatic Salvia Guide
[5-min read] California psychedelic therapy bill gets killed in committee.
[5-min read] Q&A with Bia Labate, Anthropologist & Director
[5-min read] AbbVie inks a $2B deal with psychedelic biotech Gilgamesh Pharma.
[5-min read] Q&A with Zach Leary, Facilitator & Educator
[5-min read] Oxford study identifies patient types who benefit from psilocybin therapy.
